1. Clinical Overview
Ademetionine (S-adenosyl-L-methionine or SAMe) is a naturally occurring compound found in all living cells. It serves as a critical methyl donor in numerous biochemical transmethylation reactions and is a precursor in the transsulfuration pathway for glutathione synthesis. In the Indian pharmaceutical context, it is primarily used as a hepatoprotective agent for intrahepatic cholestasis and as an adjunctive therapy for depressive disorders, leveraging its role in neurotransmitter synthesis and membrane phospholipid methylation.
| Onset | Duration | Bioavailability |
|---|---|---|
| Onset of antidepressant effect may take 1-2 weeks. Improvement in biochemical markers of cholestasis (e.g., serum bilirubin, ALP) may be observed within 1-2 weeks of therapy. | The pharmacological effects are sustained with regular dosing. The elimination half-life is approximately 100 minutes, necessitating multiple daily doses for continuous effect. | Oral bioavailability is very low (<5%) due to extensive first-pass metabolism in the liver. Therefore, the enteric-coated tablet formulation (400mg) is designed for intestinal absorption to improve systemic availability. |
2. Mechanism of Action
Ademetionine is the principal biological methyl donor. It participates in over 40 biochemical reactions. Its therapeutic effects are multifaceted: 1) Hepatoprotection: It increases hepatic glutathione levels, promoting detoxification and protecting hepatocytes from bile acid-induced apoptosis. It also increases the fluidity of hepatocyte membranes by methylating phospholipids (e.g., phosphatidylethanolamine to phosphatidylcholine), which improves bile flow and reduces intrahepatic cholestasis. 2) Antidepressant: It is involved in the synthesis of neurotransmitters (serotonin, dopamine, norepinephrine) via methylation processes and by increasing the activity of enzymes like catechol-O-methyltransferase (COMT). It also contributes to the synthesis of brain phospholipids, influencing membrane fluidity and receptor function.
3. Indications & Uses
- Intrahepatic cholestasis in pregnancy (ICP)
- Drug-induced intrahepatic cholestasis
- Chronic liver diseases (e.g., alcoholic liver disease, viral hepatitis) with cholestasis
- Adjunctive therapy in depressive disorders (especially in patients with liver disease where TCAs/SSRIs may be problematic)
4. Dosage & Administration
Adult Dosage: For cholestasis: 400-800 mg orally, twice daily. For depression: 400-800 mg orally, twice daily. Typically initiated at 400 mg twice daily and titrated based on response and tolerance.
Administration: Must be taken on an empty stomach, at least 30 minutes before a meal or 2 hours after a meal, to ensure optimal absorption. Tablets should be swallowed whole with water; do not crush, break, or chew the enteric-coated tablet.
5. Side Effects
Common side effects may include:
- Gastrointestinal: Nausea, epigastric discomfort, diarrhea, flatulence (often transient)
- Neurological: Headache, dizziness, insomnia
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Levodopa | Theoretical reduction in efficacy of Levodopa due to increased methylation and metabolism. Clinical significance is unclear. | Moderate |
| Tricyclic Antidepressants (TCAs) / SSRIs / SNRIs / MAOIs | Potential pharmacodynamic synergy, increasing risk of serotonin syndrome. Monitor for agitation, tremor, hyperreflexia. | Moderate |
| Tramadol, Meperidine | Increased risk of serotonin syndrome. | Moderate |
| Antipsychotics (e.g., Clozapine) | Possible reduced efficacy due to methylation interactions. Limited evidence. | Mild |
| Methotrexate | SAMe may reduce hepatotoxicity of methotrexate, potentially a beneficial interaction. | Beneficial |
7. Patient Counselling
- DO take the tablet on an empty stomach, at least 30 min before or 2 hours after food.
- DO swallow the tablet whole with a glass of water; do not crush or chew.
- DO inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
- DO keep all follow-up appointments to monitor liver function or mood response.
- DONT take with other antidepressants or supplements (like St. John's Wort) without doctor's approval.
- DONT stop the medication abruptly if using for depression; consult your doctor.
8. Toxicology & Storage
Overdose: Limited data. Symptoms may include severe gastrointestinal distress (nausea, vomiting, diarrhea), anxiety, agitation, insomnia, and in extreme cases, serotonin syndrome-like symptoms if combined with other agents.
Storage: Store below 30°C. Protect from light and moisture. Keep the tablets in their original blister pack until use. Keep out of reach of children.